A Study of Enicepatide (CT-388) in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity
Public ClinicalTrials.gov record NCT06525935. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of Once-Weekly CT-388 Administered for 48 Weeks to Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity
Study identification
- NCT ID
- NCT06525935
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Carmot Therapeutics, Inc.
- Industry
- Enrollment
- 469 participants
Conditions and interventions
Conditions
Interventions
- Enicepatide Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 15, 2024
- Primary completion
- Dec 7, 2025
- Completion
- Dec 7, 2025
- Last update posted
- Apr 16, 2026
2024 – 2025
United States locations
- U.S. sites
- 34
- U.S. states
- 16
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alabama Clinical Therapeutics, LLC | Birmingham | Alabama | 35235 | — |
| Central Alabama Research | Homewood | Alabama | 35209 | — |
| The Institute for Liver Health II LLC dba Arizona Clinical Trials; Arizona Liver Health | Mesa | Arizona | 85210 | — |
| Amicis Research Center - Anaheim | Anaheim | California | 92801 | — |
| Ark Clinical-Fountain Valley | Fountain Valley | California | 92708 | — |
| Ark Clinical Research - Long Beach | Long Beach | California | 90806 | — |
| Velocity Clinical Research - Los Angeles | Los Angeles | California | 90057 | — |
| Infinity Clinical Research | Norco | California | 92860 | — |
| Amicis Research Center | Northridge | California | 91324 | — |
| Prospective Research Innovations Inc. | Rancho Cucamonga | California | 91730 | — |
| Orange County Research Center | Tustin | California | 92780 | — |
| Amicis Research Center - West Hills | West Hills | California | 91307 | — |
| Tampa Bay Medical Research, Inc. | Clearwater | Florida | 33761 | — |
| Progressive Medical Research | Port Orange | Florida | 32127 | — |
| Louisville Metabolic and Atherosclerosis Research Center (L-MARC) | Louisville | Kentucky | 40213 | — |
| The Center for Pharmaceutical Research | Kansas City | Missouri | 64114 | — |
| Mercury Street Medical Group | Butte | Montana | 59701 | — |
| Neurobehavioral Research, Inc. (NBR) | Cedarhurst | New York | 11516 | — |
| Lucas Research, Inc | Morehead City | North Carolina | 28557 | — |
| Velocity Clinical Research - Cincinnati | Cincinnati | Ohio | 45242 | — |
| Velocity Clinical Research, Providence | East Greenwich | Rhode Island | 02818 | — |
| Tribe Clinical Research | Greenville | South Carolina | 29607 | — |
| Alliance for Multispecialty Research, LLC | Knoxville | Tennessee | 37920 | — |
| Clinical Research Associates, Inc. | Nashville | Tennessee | 37203 | — |
| Texas Diabetes & Endocrinology, P.A. | Austin | Texas | 78731 | — |
| Apex Mobile Clinical Research | Bellaire | Texas | 77401 | — |
| Velocity Clinical Research - Dallas | Dallas | Texas | 75230 | — |
| FutureSearch Trials of Dallas, LLC | Dallas | Texas | 75231 | — |
| University of Texas Southwestern | Dallas | Texas | 75390 | — |
| Pinnacle Clinical Research | San Antonio | Texas | 78229 | — |
| Elevate Clinical | Seabrook | Texas | 77586 | — |
| Impact Research Institute | Waco | Texas | 76710 | — |
| Chrysalis Clinical Research | St. George | Utah | 84790 | — |
| National Clinical Research - Richmond, Inc | Richmond | Virginia | 23294 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06525935, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 16, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06525935 live on ClinicalTrials.gov.